Articles dans des revues avec comité de lecture (42)
  1. 13. Paesmans, M., Garcia, C., Wong, C.-Y. O. C., Patz Jr., E. F., Komaki, R., Eschmann, S., Govindan, R., Vansteenkiste, J., Meert, A.-P., de Jong, W. K., Altorki, N. K., Higashi, K., Van Baardwijk, A., Borst, G. R., Ameye, L., Lafitte, J.-J., Berghmans, T., Flamen, P., Rami-Porta, R., & Sculier, J.-P. (2015). Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data. The European respiratory journal, 46(6), 1751-1761. doi:10.1183/13993003.00099-2015
  2. 14. Hendlisz, A., Deleporte, A., Delaunoit, T., Marechal, R., Peeters, M., Holbrechts, S., Van Den Eynde, M., Houbiers, G., Filleul, B., Van Laethem, J.-L., Ceyssens, S., Barbuto, A.-M., Lhommel, R., Demolin, G., Garcia, C., El Mansy, H., Ameye, L., Moreau, M., Guiot, T., Paesmans, M., Piccart-Gebhart, M., Flamen, P., & Santini, D. (2015). The prognostic significance of metabolic response heterogeneity in metastatic colorectal cancer. PloS one, 10(9), e138341. doi:10.1371/journal.pone.0138341
  3. 15. Bouazza, F., Poncelet, A., Garcia, C., Delatte, P., Engelhom, J. L., Gomez-Galdon, M., Deleporte, A., Hendlisz, A., Vanderlinden, B., Flamen, P., & Donckier De Donceel, V. (2015). Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma. World Journal of Gastroenterology, 21(32), 9666-9670. doi:10.3748/wjg.v21.i32.9666
  4. 16. Hendlisz, A., Golfinopoulos, V., Deleporte, A., Mansy, H. E., Vandeputte, C., Maetens, M. M., Awada, A., Piccart-Gebhart, M., Paesmans, M., Garcia, C., Flamen, P., Peeters, M., Annemans, L., Van Den Eynde, M., Borbath, I., Dresse, D., Houbiers, G., Fried, M., Marechal, R., & Van Laethem, J.-L. (2015). Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study [BMC Cancer, 13, (2013), 190]. BMC cancer, 15(1), 173. doi:10.1186/s12885-015-1181-5
  5. 17. Hendlisz, A., Deleporte, A., Vandeputte, C., Charette, N., Paesmans, M., Guiot, T., Garcia, C., & Flamen, P. (2015). Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol. BMJ open, 5(3), e007189. doi:10.1136/bmjopen-2014-007189
  6. 18. Amzerin, M., Garcia, C., Stanciu, C., Veys, I., Awada, A., Errihani, H., & Gombos, A. (2014). Case Report: Mammary and rectal metastases from an ovarian cancer: Report of two cases and review of literature. F1000Research, 3. doi:10.12688/f1000research.2644.2
  7. 19. Garcia, C. (2014). Apport de l'imagerie médicale fonctionnelle dans le diagnostic du nodule pulmonaire. Revue des Maladies Respiratoires Actualites, 6(4), 363-372. doi:10.1016/S1877-1203(14)70590-7
  8. 20. Deleporte, A., Paesmans, M., Garcia, C., Vandeputte, C., Lemort, M., Engelholm, J. L., Hoerner, F., Aftimos, P., Awada, A., Charette, N., Machiels, G., Piccart-Gebhart, M., Flamen, P., & Hendlisz, A. (2014). Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: The CORIOLAN study. BMC cancer, 14(1), 385. doi:10.1186/1471-2407-14-385
  9. 21. Orlhac, F., Soussan, M., Buvat, I., Maisonobe, J.-A., Garcia, C., & Vanderlinden, B. (2014). Tumor texture analysis in 18F-FDG PET: Relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis. The Journal of nuclear medicine, 55(3), 414-422. doi:10.2967/jnumed.113.129858
  10. 22. Berghmans, T., Cortot, A., CsToth, I., Garcia, C., Giner-Marco, V., Grigoriu, B., Holbrechts, S., Lafitte, J.-J., Meert, A.-P., Moretti, L., Paesmans, M., Remmelink, M., Richez, M., Roelandts, M., Scherpereel, A., Tulippe, C., Van Houtte, P., Sculier, J.-P., & European Lung Cancer Working Party, (2014). Les recommandations de pratique clinique de l'European Lung Cancer Working Party: Mises à jour. Revue médicale de Bruxelles, 35(3), 132-133.
  11. 23. Coleman, R., Aksnes, A. K., Naume, B., Garcia, C., Piccart-Gebhart, M., Flamen, P., Jerusalem, G., Vobecky, N., & Thuresson, M. (2014). A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease. Breast cancer research and treatment, 145(2), 411-418. doi:10.1007/s10549-014-2939-1
  12. 24. Gebhart, G., Gamez, C., Holmes, E., Robles Barba, J., Garcia, C., Cortés, M., de Azambuja, E., Fauria, K., van Dooren, V., Aktan, G., Coccia-Portugal, M., Kim, S.-B., Vuylsteke, P., Cure, H., Eidtmann, H., Baselga, J., Piccart-Gebhart, M., Flamen, P., & Di Cosimo, S. (2013). 18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO. The Journal of nuclear medicine, 54(11), 1862-1868. doi:10.2967/jnumed.112.119271
    13. << Précédent 1 2 3 4 5 Suivant >>